Dermatology News

The use of personal care products was associated with endocrine-disrupting chemicals called phthalates in children aged as young as 4 years, according to a study.

An artificial intelligence system predicted the severity of ocular symptoms in Stevens-Johnson syndrome with toxic epidural necrolysis 5 years after diagnosis, according to a study published in Allergy.

Researchers confirmed that the interleukin-1 receptor-associated kinase 4 protein plays a role in the pathogenesis of hidradenitis suppurativa and that a degrader treatment may impact the disease, according to a study.

The FDA has issued a rare pediatric disease designation to Ilya Pharma for its topical emilimogene sigulactibac treatment for STING-associated vasculopathy with onset in infancy, according to a press release.

Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.

Professional fulfillment can be achieved through a culture of wellness, efficiency of practice in the workplace and personal resilience, according to a speaker at the Ending Clinician Burnout Global Summit.

Blue-collar workers with psoriatic arthritis demonstrate an increased risk for work disability vs. white-collar workers with the same disease, according to data published in Clinical Rheumatology.

As kids return to school, the CDC has reminded the public that children with lice do not need to cut their school day short and be sent home early.

Patients with increasing numbers of cutaneous neurofibromas experienced a growing negative impact on their quality of life, especially if there was facial involvement, according to a study.

Infliximab biosimilar uptake increased by no more than just 5% annually following the release of its first two biosimilars, but then shot up by 13% to 16% for most patients after a third option emerged, according to data.